Literature DB >> 32918267

Oral Antibiotics for Acne.

Dillon J Patel1, Neal Bhatia2.   

Abstract

Oral antibiotics are integral for treating inflammatory acne based on what is understood about the pathogenesis as well as the role of Cutibacterium acnes. However, rising concerns of antibiotic resistance and the perception of "antibiotic phobia" create potential limitations on their integration in an acne treatment regimen. When prescribing oral antibiotics, dermatologists need to consider dosage, duration, and frequency, and to avoid their use as monotherapy. These considerations are important, along with the use of newer strategies and compounds, to reduce adverse-event profiles, antibiotic resistance, and to optimize outcomes. Aside from concomitant medications, allergies, and disease severity, costs and patient demographics can influence variability in prescribing plans. There are multiple published guidelines and consensus statements for the USA and Europe to promote safe antibiotic use by dermatologists. However, there is a lack of head-to-head studies and evidence for comparative superiority of any individual antibiotic, as well as any evidence to support the use of agents other than tetracyclines. Although oral antibiotics are one of the main options for moderate to severe acne, non-antibiotic therapy such as isotretinoin and hormonal therapies should be considered. As newer therapies and more outcomes data emerge, so will improved management of antibiotic therapy to foster patient safety.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32918267     DOI: 10.1007/s40257-020-00560-w

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  55 in total

Review 1.  The evolving role of Propionibacterium acnes in acne.

Authors:  J J Leyden
Journal:  Semin Cutan Med Surg       Date:  2001-09

2.  Inflammatory events are involved in acne lesion initiation.

Authors:  Anthony H T Jeremy; Diana B Holland; Susan G Roberts; Kathryn F Thomson; William J Cunliffe
Journal:  J Invest Dermatol       Date:  2003-07       Impact factor: 8.551

Review 3.  A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines.

Authors:  James Q Del Rosso
Journal:  Cutis       Date:  2004-08

4.  European evidence-based (S3) guidelines for the treatment of acne.

Authors:  A Nast; B Dréno; V Bettoli; K Degitz; R Erdmann; A Y Finlay; R Ganceviciene; M Haedersdal; A Layton; J L López-Estebaranz; F Ochsendorf; C Oprica; S Rosumeck; B Rzany; A Sammain; T Simonart; N K Veien; M V Zivković; C C Zouboulis; H Gollnick
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-02       Impact factor: 6.166

Review 5.  Tetracyclines: nonantibiotic properties and their clinical implications.

Authors:  Allen N Sapadin; Raul Fleischmajer
Journal:  J Am Acad Dermatol       Date:  2006-02       Impact factor: 11.527

6.  Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill propionibacterium acnes.

Authors:  Dong-Youn Lee; Kenshi Yamasaki; Jennifer Rudsil; Christos C Zouboulis; Geon Tae Park; Jun-Mo Yang; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2008-01-17       Impact factor: 8.551

Review 7.  Guidelines of care for the management of acne vulgaris.

Authors:  Andrea L Zaenglein; Arun L Pathy; Bethanee J Schlosser; Ali Alikhan; Hilary E Baldwin; Diane S Berson; Whitney P Bowe; Emmy M Graber; Julie C Harper; Sewon Kang; Jonette E Keri; James J Leyden; Rachel V Reynolds; Nanette B Silverberg; Linda F Stein Gold; Megha M Tollefson; Jonathan S Weiss; Nancy C Dolan; Andrew A Sagan; Mackenzie Stern; Kevin M Boyer; Reva Bhushan
Journal:  J Am Acad Dermatol       Date:  2016-02-17       Impact factor: 11.527

Review 8.  Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms.

Authors:  L M Golub; H M Lee; M E Ryan; W V Giannobile; J Payne; T Sorsa
Journal:  Adv Dent Res       Date:  1998-11

9.  The prevalence of acne in adults 20 years and older.

Authors:  Christin N Collier; Julie C Harper; Jennifer A Cafardi; Wendy C Cantrell; Wenquan Wang; K Wade Foster; Boni E Elewski
Journal:  J Am Acad Dermatol       Date:  2007-10-22       Impact factor: 11.527

Review 10.  The epidemiology of acne vulgaris in late adolescence.

Authors:  Darren D Lynn; Tamara Umari; Cory A Dunnick; Robert P Dellavalle
Journal:  Adolesc Health Med Ther       Date:  2016-01-19
View more
  3 in total

Review 1.  Tetracyclines and bone: Unclear actions with potentially lasting effects.

Authors:  Amy J Warner; Jessica D Hathaway-Schrader; Rena Lubker; Christopher Davies; Chad M Novince
Journal:  Bone       Date:  2022-03-03       Impact factor: 4.626

2.  Gelidiales Are Not Just Agar-Revealing the Antimicrobial Potential of Gelidium corneum for Skin Disorders.

Authors:  Margarida Matias; Susete Pinteus; Alice Martins; Joana Silva; Celso Alves; Teresa Mouga; Helena Gaspar; Rui Pedrosa
Journal:  Antibiotics (Basel)       Date:  2022-04-05

3.  Antibiotic Resistance Risk with Oral Tetracycline Treatment of Acne Vulgaris.

Authors:  Madisen A Swallow; Ryan Fan; Jeffrey M Cohen; Christopher G Bunick
Journal:  Antibiotics (Basel)       Date:  2022-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.